Filing Details
- Accession Number:
- 0001144204-17-053029
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-18 16:16:54
- Reporting Period:
- 2017-10-17
- Accepted Time:
- 2017-10-18 16:16:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1138776 | Aevi Genomic Medicine Inc. | GNMX | Biological Products, (No Disgnostic Substances) (2836) | 980217544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1353128 | Gayle Barbara Duncan | C/O Aevi Genomic Medicine, Inc. 435 Devon Park Drive, Suite 715 Wayne PA 19087 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-10-17 | 59,524 | $1.26 | 59,524 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant (right to buy) | Acquisiton | 2017-10-17 | 10,591 | $0.00 | 10,591 | $2.84 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 10,591 | 2017-10-17 | 2022-10-17 | No | 4 | P | Direct |
Billionaire Hedge Funds
